These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19435416)

  • 1. Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.
    Mustafa W; Maciag PC; Pan ZK; Weaver JR; Xiao Y; Isaacs SN; Paterson Y
    Viral Immunol; 2009 Jun; 22(3):195-204. PubMed ID: 19435416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
    Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
    Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site.
    Lamikanra A; Pan ZK; Isaacs SN; Wu TC; Paterson Y
    J Virol; 2001 Oct; 75(20):9654-64. PubMed ID: 11559797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
    Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
    Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
    Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
    J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2-M3-restricted T cells participate in the priming of antigen-specific CD4+ T cells.
    Chow MT; Dhanji S; Cross J; Johnson P; Teh HS
    J Immunol; 2006 Oct; 177(8):5098-104. PubMed ID: 17015693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model.
    Bahey-El-Din M; Casey PG; Griffin BT; Gahan CG
    Vaccine; 2008 Sep; 26(41):5304-14. PubMed ID: 18691625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.
    Passmore JA; Burch VC; Shephard EG; Marais DJ; Allan B; Kay P; Rose RC; Williamson AL
    J Med Virol; 2002 Jun; 67(2):234-40. PubMed ID: 11992584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors.
    Bahey-El-Din M; Casey PG; Griffin BT; Gahan CGM
    J Med Microbiol; 2010 Aug; 59(Pt 8):904-912. PubMed ID: 20488938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prokaryotic expression of Listeria monocytogenes (LM) hly and development of monoclonal antibodies against listeriolysin O (LLO)].
    Luo Z; Liu R; Zheng S
    Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1652-7. PubMed ID: 20222463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Listeriolysin o is strongly immunogenic independently of its cytotoxic activity.
    Carrero JA; Vivanco-Cid H; Unanue ER
    PLoS One; 2012; 7(3):e32310. PubMed ID: 22403645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolysin-dependent escape of the bacterium from the phagosome is required but not sufficient for induction of the Th1 immune response against Listeria monocytogenes infection: distinct role of Listeriolysin O determined by cytolysin gene replacement.
    Hara H; Kawamura I; Nomura T; Tominaga T; Tsuchiya K; Mitsuyama M
    Infect Immun; 2007 Aug; 75(8):3791-801. PubMed ID: 17517863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.
    Ozawa Y; Suda T; Nagata T; Hashimoto D; Nakamura Y; Enomoto N; Inui N; Koide Y; Nakamura H; Chida K
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):440-8. PubMed ID: 19202004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
    Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
    J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
    Ikonomidis G; Paterson Y; Kos FJ; Portnoy DA
    J Exp Med; 1994 Dec; 180(6):2209-18. PubMed ID: 7964496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
    Park JS; Oh YK; Kang MJ; Kim CK
    J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine.
    Namvar A; Bolhassani A; Javadi G; Noormohammadi Z
    Sci Rep; 2019 Oct; 9(1):15225. PubMed ID: 31645650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes.
    Dupuy C; Buzoni-Gatel D; Touzé A; Bout D; Coursaget P
    J Virol; 1999 Nov; 73(11):9063-71. PubMed ID: 10516012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
    Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
    Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.